Chinese english Germany Japanese Korea

Bacopaside IV

Bacopaside IV Struktur
155545-03-2
CAS-Nr.
155545-03-2
Englisch Name:
Bacopaside IV
Synonyma:
Bacopaside IV;α-L-Arabinopyranoside, (3β,16β,23R)-16,23:16,30-diepoxy-20-hydroxydammar-24-en-3-yl 3-O-β-D-glucopyranosyl-
CBNumber:
CB75544256
Summenformel:
C41H66O13
Molgewicht:
766.97
MOL-Datei:
155545-03-2.mol
Request For Quotation

Bacopaside IV Eigenschaften

Schmelzpunkt:
272-274 °C (decomp)(Solv: methanol (67-56-1))
Siedepunkt:
881.1±65.0 °C(Predicted)
Dichte
1.35±0.1 g/cm3(Predicted)
pka
12.82±0.70(Predicted)

Sicherheit

Bacopaside IV Chemische Eigenschaften,Einsatz,Produktion Methoden

Bacopaside IV Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Bacopaside IV Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 18)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Chengdu Biopurify Phytochemicals Ltd. 		+8618080483897
 sales@biopurify.com China 3424 58
Hubei Ipure Biology Co., Ltd 		+8613367258412
 ada@ipurechemical.com China 10326 58
TargetMol Chemicals Inc. 		+1-781-999-5354
support@targetmol.com United States 19973 58
ShenZhen Trendseen Biological Technology Co.,Ltd. 		13417589054
 trendseenbio@gmail.com China 11681 58
Shandong Xiya Chemical Co., Ltd 13355009207 13355009207
 3007715519@qq.com China 18739 57
Wuxi Zhongkun Biochemical Technology Co., Ltd. 0510-85629785 18013409632
 sales@reading-chemicals.com China 15185 58
Wuhan ChemFaces Biochemical Co., Ltd. 18607101326 15172504745
 aileen@chemfaces.com China 7059 55
Chengdu Push Bio-Technology Co., Ltd. 028-85370565-229 18080489829
 3004654993@qq.com China 9176 60
Nanjing Digger Medical Technology Co. Ltd. 025-025-51191215 18013836722
 2399235533@qq.com China 4933 58
Shanghai Bohu Biotechnology Co., LTD 021-57763112 13585886131
 3004987436@qq.com China 9694 58
  • Bacopaside IV
  • α-L-Arabinopyranoside, (3β,16β,23R)-16,23:16,30-diepoxy-20-hydroxydammar-24-en-3-yl 3-O-β-D-glucopyranosyl-
  • 155545-03-2
Copyright 2019 © ChemicalBook. All rights reserved